idh inhibitors for aml: highlights from ash 2018
Published 5 years ago • 82 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:32
idh inhibitors for aml and mds
-
2:13
a success story: idh inhibitors for aml
-
1:44
improving maintenance therapy in aml: exploring the role of idh inhibitors
-
2:22
session highlights: idh inhibitors, salvage regimens, and other novel developments in aml
-
0:54
idh inhibitors and the evolving aml treatment paradigm
-
0:59
idh inhibitors in aml
-
1:23
decitabine, venetoclax, and idh inhibitor in idh-mutated aml
-
1:51
idh1/2 inhibitors for upfront aml therapy and transfusion independence
-
2:08
the impact of idh mutations on the outcomes of patients with aml & inhibitors under investigation
-
1:48
idh1 inhibitor ivosidenib for the treatment of relapsed/ refractory aml
-
2:21
the future of aml treatment? progress in idh1/2 inhibitors for aml
-
3:08
venetoclax-idh inhibitor combination therapy for aml
-
2:50
idh inhibition in aml therapy
-
2:57
targeting idh mutations for the treatment of aml
-
1:53
treatment strategies for patients with idh1/2-mutated aml ineligible for intensive chemotherapy
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
1:24
toxicity profiles of idh inhibitors: are they as intimidating as they seem?
-
8:50
idh inhibitors for aml
-
1:27
how do targeted treatments for idh1 and idh2 mutations work in acute myeloid leukemia (aml)?